Evaluation of the Individual Safe Correction of Antipsychotic Agent Polypharmacy in Japanese Patients with Chronic Schizophrenia: Validation of Safe Corrections for Antipsychotic Polypharmacy and the High-Dose Method

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan

(2014) Tsuruhei Sukegawa et al.   BMC Psychiatry

Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009

(2012) Takashi Yoshio et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Critical review of antipsychotic polypharmacy in the treatment of schizophrenia

(2012) W. Wolfgang Fleischhacker et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Effectiveness of Switching From Antipsychotic Polypharmacy to Monotherapy

(2011) Susan M. Essock et al.   AMERICAN JOURNAL OF PSYCHIATRY

Antipsychotic Polypharmacy in Schizophrenia

(2011) Thomas R.E. Barnes et al.   CNS DRUGS

Antipsychotic Polypharmacy in Inpatients with Schizophrenia in Asia (2001−2009)

(2011) Y.-T. Xiang et al.   PHARMACOPSYCHIATRY

Issues in Outcomes Research: An Overview of Randomization Techniques for Clinical Trials

(2009) Minsoo Kang et al.   JOURNAL OF ATHLETIC TRAINING

Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials

(2008) C. U. Correll et al.   SCHIZOPHRENIA BULLETIN